This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Delivered as a Hybrid Event
February 27 - March 2, 2023San Diego Convention Center

Mike Vandiver
Site Head, Launch Pad Manufacturing, Executive Director, Manufacturing at Seattle Genetics


Michael (Mike) Vandiver is Executive Director, Launchpad Mfg., at Seagen, Inc. Mike has over 30 years of biopharmaceutical industry experience. This includes design, qualification and operation of multiple cGMP biologics drug substance manufacturing facilities, configured to produce early phase clinical to commercial material supporting multi-regional clinical programs and global commercial markets. At Seagen, Mike is the Launchpad Site Head and responsible for operational readiness and manufacturing operations.

Prior to Seagen, Mike spent 7 years at Just-Evotec Biologics, as Senior Vice President Biotherapeutic Operations, where he led the effort to bring J.Plant and J.POD clinical and commercial biomanufacturing facilities online. He also spent 15 years at Amgen in Director and Principal Scientist roles and was an architect of Amgen’s Manufacturing of the Future (MoF) initiative that enabled highly productive and cost-effective biologics manufacturing. Prior to Amgen, he held clinical production and process development managerial roles at ICOS Corporation and Scantibodies Laboratories. Mike received his Bachelor of Science in Microbiology from the University of Washington. He is also a Registered Microbiologist (R.M.) with the American Academy of Microbiology in Research & Developmental Microbiology

Agenda Sessions

  • Project Launch Pad - Design Efforts for New Facility in Everett, WA